NEW YORK (GenomeWeb News) – Crescendo Bioscience today announced Medicare is covering its Vectra DA test for rheumatoid arthritis.

Medicare contractor Palmetto GBA has established national coverage for the South San Francisco, Calif. firm's test for assessing RA activity, in conjunction with standard clinical assessment, in adults who previously were diagnosed with the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.